Client of a consultant lobbyist
Canadian Antimicrobial Innovation Coalition
- Meetings this Parliament
- 4
- With MPs
- 3
- Since Nov 2021
- 6
- Active registrations
- 1
Most recent reported meeting: Mar 2, 2026.
Lobbying by Canadian Antimicrobial Innovation Coalition: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Jan 15, 2025
Consultant Danielle Peters of Magnet Strategy Group
Consultant lobbyists
- Danielle Peters
- Danielle Peters
- Danielle Peters
Institutions they may lobby: Canadian Institutes of Health Research (CIHR), Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Public Health Agency of Canada (PHAC)
What they're lobbying on (2)Hide details
- Advocate for push and pull incentives to stimulate innovation in antimicrobials R&D and access, and incentives to encourage innovation in antimicrobial stewardship and antimicrobial alternatives. Promote a one-health approach to countering antimicrobial resistance.
- Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control.
Registration 782641-367825-5. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Danielle Peters · Consultant
- Maggie Chi · Parliamentary Secretary, Health Canada (HC)
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control. Read more
-
Reported by Danielle Peters · Consultant
- Dan Mazier · Member of Parliament
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control. Read more
Advocate for push and pull incentives to stimulate innovation in antimicrobials R&D and access, and incentives to encourage innovation in antimicrobial stewardship and antimicrobial alternatives. Promote a one-health approach to countering antimicrobial resistance.
-
Reported by Danielle Peters · Consultant
- Maggie Chi · MP
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control. Read more
Advocate for push and pull incentives to stimulate innovation in antimicrobials R&D and access, and incentives to encourage innovation in antimicrobial stewardship and antimicrobial alternatives. Promote a one-health approach to countering antimicrobial resistance.
-
Reported by Danielle Peters · Consultant
- Sandenga Yerba · Director of Policy/Deputy Chief if Staff, Health Canada (HC)
Address the growing public health threat of antimicrobial resistance through policy to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies; and policy to promote innovation in antimicrobial stewardship, surveillance and infection prevention and control. Read more
-
Reported by Danielle Peters · Consultant
- Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealth
-
Reported by Danielle Peters · Consultant
- François-Olivier Picard · Policy advisor, Health Canada (HC)
HealthResearch and Development
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.